← All trials
NCT02771587
Phase 1Interventional
Includes initial studies to determine the metabolism and pharmacologic actions of drugs in humans, the side effects associated with increasing doses, and to gain early evidence of effectiveness; may include healthy participants and/or patients.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jun 30, 2016
- Primary completion
- Sep 30, 2016
- Completion date
- Sep 30, 2016
- First posted
- May 13, 2016
- Last posted
- Oct 19, 2016
- Enrollment
- 16
- Arms / groups
- 4 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Institut Hospital del Mar d'Investigacions MèdiquesLead sponsor
- Fundació IMIM - Parc de Salut MarOverall official - principal investigator
- Institut Hospital del Mar d'Investigacions MèdiquesReponsible party - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.